Lixisenatide for Restoration of Insulin Release in Subjects With Diabetes Mellitus Type 2

NCT00931372 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Lixisenatide (AVE0010)
DRUG: Placebo

Sponsor

Sanofi

Collaborators

[object Object]